Literature DB >> 9245850

Heterogeneity of atypical haemolytic uraemic syndromes.

T J Neuhaus1, S Calonder, E P Leumann.   

Abstract

Atypical, non-diarrhoea associated haemolytic uraemic syndrome (D-HUS) is a heterogeneous disorder with a generally poor outcome, although this view has now been questioned. The clinical and laboratory features of 23 children with D-HUS, representing a third of all patients with HUS seen during the last 26 years, were examined. The median age was 4.9 years (range 3 days-13.8 years). Twenty one children (91%) survived the initial phase. All patients except six infants aged < 18 months required dialysis (74%). Hypertension (43%), cardiomyopathy (43%), and cerebral convulsions (48%) were common. Nineteen (83%) children were followed up for a median period of 5.5 years (range 0.5-23.4). Only five (26%) patients, among them four infants, recovered completely. Six (32%) patients had one to 10 recurrences, including two siblings with neonatal onset, and eight (42%) developed end stage renal failure. Five children underwent cadaveric renal transplantation, with recurrence and subsequent graft failure in two. Four children died, resulting in an overall mortality of 26%. Atypical HUS is heterogeneous with regard to epidemiology, pathophysiology, and outcome. Children with a recurrent, familial, or neonatal course have worse outcomes; in contrast, infants not requiring dialysis in the acute phase have a better prognosis.

Entities:  

Mesh:

Year:  1997        PMID: 9245850      PMCID: PMC1717216          DOI: 10.1136/adc.76.6.518

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  37 in total

1.  The hemolytic uremic syndrome diagnosis and treatment with special reference to disseminated intravascular coagulation.

Authors:  H Michalsen; B D Andersen; H C Godal
Journal:  J Oslo City Hosp       Date:  1975-08

2.  [Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia].

Authors:  C GASSER; E GAUTIER; A STECK; R E SIEBENMANN; R OECHSLIN
Journal:  Schweiz Med Wochenschr       Date:  1955-09-20

Review 3.  Report on management of renal failure in Europe, XXV, 1994. The child-adult interface. The EDTA-ERA Registry. European Dialysis and Transplant Association-European Renal Association.

Authors:  O Mehls; S Rigden; J H Ehrich; F Berthoux; E H Jones; F Valderrábano
Journal:  Nephrol Dial Transplant       Date:  1996       Impact factor: 5.992

4.  Chronic microangiopathic hemolytic anemia. Association with Escherichia coli infections.

Authors:  S P Rao; A L Sutton; M L Falter; M G Robinson
Journal:  N Y State J Med       Date:  1979-10

5.  Fatal haemolytic-uraemic syndrome in two sibs.

Authors:  P P Anthony; A B Kaplan
Journal:  Arch Dis Child       Date:  1968-06       Impact factor: 3.791

6.  Hemolytic uremic syndrome with recurrent episodes: an important subset.

Authors:  B S Kaplan
Journal:  Clin Nephrol       Date:  1977-12       Impact factor: 0.975

7.  Hemolytic-uremic syndrome associated with neuraminidase-producing microorganisms: treatment by exchange transfusion.

Authors:  R Seger; P Joller; K Baerlocher; A Kenny; C Dulake; E Leumann; M Spierig; W H Hitzig
Journal:  Helv Paediatr Acta       Date:  1980-09

8.  Familial hypocomplementemic hemolytic uremic syndrome with HLA-A3,B7 haplotype.

Authors:  L Carreras; R Romero; C Requesens; A J Oliver; M Carrera; M Clavo; J Alsina
Journal:  JAMA       Date:  1981-02-13       Impact factor: 56.272

9.  The hemolytic-uremic syndrome: spectrum of severity and significance of prodrome.

Authors:  D Dolislager; B Tune
Journal:  Am J Dis Child       Date:  1978-01

10.  Long-term (15-25 years) outcome of childhood hemolytic-uremic syndrome.

Authors:  M F Gagnadoux; R Habib; M C Gubler; J L Bacri; M Broyer
Journal:  Clin Nephrol       Date:  1996-07       Impact factor: 0.975

View more
  22 in total

1.  Long-term investigation of kidney ultrasound in cases of hemolytic uremic syndrome in children.

Authors:  Thi Thanh Tam Bui; Heiko Billing; Abdulsattar Alrajab; Elke Wühl; Jens-Peter Schenk
Journal:  J Med Ultrason (2001)       Date:  2013-10-22       Impact factor: 1.314

Review 2.  Cardiovascular complications in atypical haemolytic uraemic syndrome.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2014-01-14       Impact factor: 28.314

3.  A time for reappraisal of "atypical" hemolytic uremic syndrome: should all patients be treated the same?

Authors:  Rebecca L Ruebner; Bernard S Kaplan; Lawrence Copelovitch
Journal:  Eur J Pediatr       Date:  2012-06-07       Impact factor: 3.183

4.  Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab.

Authors:  Kaan Gulleroglu; Kibriya Fidan; Veysel S Hançer; Umut Bayrakci; Esra Baskin; Oguz Soylemezoglu
Journal:  Pediatr Nephrol       Date:  2013-02-07       Impact factor: 3.714

5.  Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder.

Authors:  Ajay P Sharma; Cheryl R Greenberg; Asuri N Prasad; Chitra Prasad
Journal:  Pediatr Nephrol       Date:  2007-09-14       Impact factor: 3.714

6.  Idiopathic Atypical Hemolytic Uremic Syndrome (aHUS) with Trilineage Myelodysplasia.

Authors:  Sudha Sethy; S R Mahapatra; R K Jena; P Bhunya; S Mahapatra
Journal:  Indian J Hematol Blood Transfus       Date:  2011-07-12       Impact factor: 0.900

Review 7.  Pathogenesis of thrombotic microangiopathies.

Authors:  X Long Zheng; J Evan Sadler
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

Review 8.  The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children.

Authors:  Chantal Loirat; Patrick Niaudet
Journal:  Pediatr Nephrol       Date:  2003-09-17       Impact factor: 3.714

Review 9.  Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura.

Authors:  Mini Michael; Elizabeth J Elliott; Greta F Ridley; Elisabeth M Hodson; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

Review 10.  Extra-renal manifestations of atypical hemolytic uremic syndrome.

Authors:  Cassandra Formeck; Agnieszka Swiatecka-Urban
Journal:  Pediatr Nephrol       Date:  2018-08-14       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.